Non-Small Cell Lung Cancer Staging and Prognosis

Learn how age impacts stage 2 lung cancer survival rates. Discover what the statistics mean for your prognosis, treatment options, and understanding lung cancer.

Navigating survival statistics after a lobectomy for lung cancer can be overwhelming. Learn how to interpret prognosis data and what it means for your recovery.

Is stage 4 lung cancer terminal? Discover why a diagnosis is no longer a single story and explore modern treatment options, remission possibilities, and care.

Confused by stage 3 vs. stage 4 lung cancer? Learn why your genetic profile and biomarker testing are more critical for treatment than the stage number alone.

Understand why outdated statistics don't reflect current stage 4 NSCLC life expectancy. Learn how targeted therapy and biomarker testing are improving prognoses.

Not all metastatic cancer behaves the same way. Some people are diagnosed with oligometastatic non-small cell lung cancer (NSCLC), a specific state of lung cancer where the disease has spread beyond the lung, but only to a limited number of sites in the body. The term “oligo” itself means “few.” In this context, it refers […]

We were fortunate to host Dr. Martin F. Dietrich, a medical oncologist at the Cancer Care Centers of Brevard and an assistant professor of internal medicine at the University of Central Florida, for a recent Outcomes4Me “Ask the Expert” webinar. You can watch Dr. Dietrich’s full webinar below. Watch the full replay here We’ve transcribed […]

Stage 2 non-small cell lung cancer (NSCLC) is a localized or regional stage of the disease that has not yet metastasized to distant organs. Survival rates at this stage provide valuable insights into prognosis and treatment outcomes for patients. The following is an overview of the survival rates for stage 2 NSCLC based on current […]

Stage 4 non-small cell lung cancer (NSCLC) is an advanced form of the disease; understanding the life expectancy with treatment is crucial for patients and their families.  Life Expectancy with Treatment: Research indicates that treatment can significantly impact the life expectancy of patients with stage 4 NSCLC. While individual outcomes vary, studies suggest that with […]

Stage 3 non-small cell lung cancer (NSCLC) is a critical stage of the disease where the tumor is very large or has spread to local or regional lymph nodes or into the surrounding chest wall. Survival rates at this stage provide important insights into prognosis and treatment outcomes for patients. The following is an overview […]

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. In fact, 85% of those who have been diagnosed with lung cancer have received a NSCLC diagnosis, versus small-cell lung cancer, which is much less common.  Some non-small lung cancers are curable depending on overall health and prognosis, which includes a variety […]

Lung Cancer Second Opinion The decision to seek out a second opinion is more common than you think. Whether you’ve just been diagnosed with NSCLC (non-small cell lung cancer) or you’re already moving toward treatment, there are valid reasons to ensure you have the most complete picture possible before embarking on treatment. In fact, seeking […]